Understanding the enzymatic, genetic, and environmental factors influencing CYP2E1 activity is essential for developing predictive biomarkers, optimizing TB therapy regimens, and identifying individuals at higher risk for liver injury. The gene discussed is CYP2E1; the disease is tuberculosis.